SCHEMBL16487101

SCHEMBL16487101

CCCCc1nc2c(N)nc(-c3ccsc3)cc2n1Cc1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 20/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16487205 0.89 TLR7 (0.79) TLR7
SCHEMBL17819064 0.82 TLR7 (0.70) TLR7
SCHEMBL16486329 0.82 TLR7 (0.69) TLR7
SCHEMBL16487106 0.82 TLR7 (1.00) TLR7
SCHEMBL17819063 0.82 TLR7 (0.48) TLR7
SCHEMBL16486422 0.81 TLR7 (1.00) TLR7
SCHEMBL16486464 0.81 TLR7 (0.67) TLR7
SCHEMBL16486971 0.80 TLR7 (1.00) TLR7
SCHEMBL16487350 0.80 TLR7 (0.80) TLR7
SCHEMBL16486373 0.78 TLR7 (1.00) TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10471139-B2 Toll-like receptor agonists THE UNIVERSITY OF KANSAS (US) 2019-11-12 US disclosed
US-20160166681-A1 TOLL-LIKE RECEPTOR AGONISTS THE UNIVERSITY OF KANSAS 2016-06-16 US disclosed
WO-2015023958-A1 TOLL-LIKE RECEPTOR AGONISTS THE UNIVERSITY OF KANSAS (US) 2015-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160166681-A1 TOLL-LIKE RECEPTOR AGONISTS TLR1, TLR7, TLR8 TLR7 2/4885
US-10471139-B2 Toll-like receptor agonists TLR1, TLR7, TLR8 TLR7 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.